Lalimos, Luela C.
HRN: 27-53-89 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/27/2025
08/03/2025
IVT
1.5g
Q6
Cellulitis
Checking Initial Appropriateness
07/27/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/27/2025
08/03/2025
IVT
600mg
Q8
Cellulitis
Checking Initial Appropriateness
08/04/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/04/2025
08/11/2025
IV
250 Mg
OD
Klebsiella Pneumoniae Infection
Checking Initial Appropriateness
08/04/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/04/2025
08/11/2025
IVTT
250mg
Q 12h
EMPIRIC
Checking Initial Appropriateness
08/05/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/27/2025
08/26/2025
IVTT
600mg
Q8
Cellulitis
Checking Initial Appropriateness